HomeCompareCME vs KLAC

CME vs KLAC: Dividend Comparison 2026

CME yields 1.75% · KLAC yields 0.55%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CME wins by $3.25M in total portfolio value
10 years
CME
CME
● Live price
1.75%
Share price
$297.58
Annual div
$5.20
5Y div CAGR
85.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.05M
Annual income
$3,278,693.93
Full CME calculator →
KLAC
KLAC
● Live price
0.55%
Share price
$1,382.58
Annual div
$7.60
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$795.3K
Annual income
$589,306.66
Full KLAC calculator →

Portfolio growth — CME vs KLAC

📍 CME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCMEKLAC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CME + KLAC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CME pays
KLAC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CME
Annual income on $10K today (after 15% tax)
$148.53/yr
After 10yr DRIP, annual income (after tax)
$2,786,889.84/yr
KLAC
Annual income on $10K today (after 15% tax)
$46.72/yr
After 10yr DRIP, annual income (after tax)
$500,910.66/yr
At 15% tax rate, CME beats the other by $2,285,979.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CME + KLAC for your $10,000?

CME: 50%KLAC: 50%
100% KLAC50/50100% CME
Portfolio after 10yr
$2.42M
Annual income
$1,934,000.30/yr
Blended yield
79.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KLAC right now

CME
Analyst Ratings
13
Buy
17
Hold
5
Sell
Consensus: Hold
Price Target
$311.83
+4.8% upside vs current
Range: $300.00 — $340.00
Altman Z
0.6
Piotroski
5/9
KLAC
Analyst Ratings
27
Buy
14
Hold
2
Sell
Consensus: Buy
Price Target
$1,696.31
+22.7% upside vs current
Range: $1,400.00 — $1,900.00
Altman Z
12.3
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CME buys
0
KLAC buys
8
PoliticianChamberTickerTypeAmountDate
Val Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-09-23
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002025-07-28
Valerie Hoyle🏢 House$KLAC▼ Sell$1,001 - $15,0002025-04-29
William R. Keating🏢 House$KLAC▲ Buy$1,001 - $15,0002025-01-24
Gilbert Cisneros🏢 House$KLAC▼ Sell$1,001 - $15,0002025-01-13
Valerie Hoyle🏢 House$KLAC▲ Buy$1,001 - $15,0002024-10-29
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-09-04
John James🏢 House$KLAC▼ Sell$1,001 - $15,0002024-06-26
Tommy Tuberville🏛 Senate$KLAC▼ Sell$1,001 - $15,0002024-05-03
Ro Khanna🏢 House$KLAC▲ Buy$1,001 - $15,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCMEKLAC
Forward yield1.75%0.55%
Annual dividend / share$5.20$7.60
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR85.4%100%
Portfolio after 10y$4.05M$795.3K
Annual income after 10y$3,278,693.93$589,306.66
Total dividends collected$3.96M$757.1K
Payment frequencyquarterlyquarterly
SectorFinancialsTechnology
Analyst consensusHoldBuy
Analyst price target$311.83$1,696.31

Year-by-year: CME vs KLAC ($10,000, DRIP)

YearCME PortfolioCME Income/yrKLAC PortfolioKLAC Income/yrGap
1← crossover$11,024$323.97$10,810$109.94+$214.00CME
2$12,414$618.83$11,789$222.14+$625.00CME
3$14,491$1,207.51$13,067$452.81+$1.4KCME
4$17,948$2,442.23$14,920$938.13+$3.0KCME
5$24,445$5,241.07$17,966$2,002.14+$6.5KCME
6$38,525$12,368.84$23,730$4,506.49+$14.8KCME
7$74,998$33,775.95$36,517$11,125.83+$38.5KCME
8$194,178$113,930.22$71,075$32,001.78+$123.1KCME
9$718,883$511,112.41$192,474$116,423.57+$526.4KCME
10$4,047,898$3,278,693.93$795,254$589,306.66+$3.25MCME

CME vs KLAC: Complete Analysis 2026

CMEFinancials

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

Full CME Calculator →

KLACTechnology

KLA Corporation designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through four segments: Semiconductor Process Control; Specialty Semiconductor Process; PCB, Display and Component Inspection; and Other. The company offers integrated circuit (IC) manufacturing products that comprises wafer inspection and review, and metrology; wafer and substrate defect inspection and metrology; reticle defect inspection and metrology; chemical/materials quality analysis; in situ process management and wafer handling diagnostics for IC and original equipment manufacturer (OEM) manufacturing; software products to provide run-time process control, defect excursion identification, process corrections, and defect classification; and refurbished and remanufactured products. It also provides specialty semiconductor manufacturing, benchtop metrology, surface characterization, and electrical property measurement services for general purpose/ lab applications; etch, plasma dicing, deposition, and other wafer processing technologies and solutions for the semiconductor and microelectronics industry. In addition, the company offers direct imaging, inspection, optical shaping, additive printing, and computer-aided manufacturing and engineering solutions for the PCB market; inspection and electrical testing systems to identify and classify defects, as well as systems to repair defects for the display market; and inspection and metrology systems for quality control and yield improvement in advanced and traditional semiconductor packaging markets. The company was formerly known as KLA-Tencor Corporation and changed its name to KLA Corporation in July 2019. KLA Corporation was incorporated in 1975 and is headquartered in Milpitas, California.

Full KLAC Calculator →
📬

Get this CME vs KLAC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CME vs SCHDCME vs JEPICME vs OCME vs KOCME vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.